Company Info
Year Established2020
Contacts
Nicholas A. Boyle, Ph.D.President & CEO
David D. Phinney, J.D.
General Counsel
Derek Ostertag, Ph.D.
CSO
Carlos E. Iba�ez, Ph.D.
CTO
Company Description
Abintus is developing novel, off-the-shelf therapies that reprogram cells directly in vivo to improve patient outcomes and access.